Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units: A Multicenter Retrospective Cohort Study in the Beaumont Healthcare System

NCT04829552 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT04829552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units: A Multicenter Retrospective Cohort Study in the Beaumont Healthcare System
Lead sponsor
Corewell Health East
Phase
Observational
Overall status
Completed
Start date
March 10, 2020
Completion date
April 15, 2020
Enrollment
704 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19